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Abstract
Background: To date Health information (HI) in the European Union does not comprise indicators or other
information related to impacts of hazardous chemicals in consumer products, food, drinking water or air on the health
status of the population. Therefore, we inventorised and evaluated the potential of environmental health surveillance
and research data sources in the European population to provide HBM-based indicators of internal human exposure
and health impact of relevant chemicals.
Methods: We established an up-dated inventory of European cross-sectional Human Biomonitoring (HBM) surveys and
of birth cohorts, and compared chemicals and chemical groups addressed by HBM with indicators and health
end points collected via European Core Health Indicators (ECHI), in birth registries, as well as in environmental
and food data bases and health registries to see on how data collection could be aligned. Finally, we investigated study
designs of HBM survey and health examination surveys for potential synergies.
Results: The inventory covers a total of 11 European cross-sectional national programmes and a large number
of birth cohorts and includes information on study population, age groups, covered substances, sampled matrices, and
frequency. The comparison of data collections shows that there are many overlaps between environmental chemicals
with environmental and health reporting. HBM data could be linked with ECHI indicators for work-related risks, body
mass index (BMI), and low birth weight, with perinatal disease, neurologic disorders, and some chronic diseases, or with
data bases for e.g. indoor air, food, or consumer products. Existing initiatives to link data collections at European
Environment Agency (EEA) and Joint Research Center (JRC) or at World Health Organization (WHO) are good
options to further develop linkage of HBM with exposures sources and health end points.
Conclusions: There is potential to use HBM based information in a number of public health policies, and this
would help to align reporting to international commitments. Environmental health surveillance based on HBM
and HBM-based indicators, is an excellent tool to inform public health policies about risks from environmental
chemicals, and the EU health information system would benefit from additional HBM-based indicators for monitoring
exposure burden from environmental chemicals. Considerable efforts are needed to align and establish routine data
collections and to develop a surveillance system and indicators which may inform public health policies.
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Background
The Public Health Programme asks for better informa-
tion on determinants for health, and the 2030 Agenda
for Sustainable Development stresses the need to protect
citizens from hazardous chemicals, as the target 3.9 of
the 2030 Agenda asks to substantially reduce the
number of deaths and illnesses from hazardous chemi-
cals in air, water and soil pollution and contamination.
Furthermore, the Public Health Programme aims at
preventing diseases and foster supportive environments
for a healthy lifestyle, and to protect European Union
citizens from serious cross-border health threats, taking
into consideration social and gender specific differences.
The term “Health information” (HI) compromises
information, data, and evidence that describe the health
status of a population or a specific population group
whereby the information is regularly expressed in forms
of indicators. Health indicators describe health status,
determinants of health, and health care. They allow
monitoring and comparison, and serve as a basis for
policy-making. To date HI in the European Union only
comprises very few indicators related to internal human
exposure and health impact of tobacco smoke and
particulate matter but does not include any indicator
related to other hazardous chemicals in consumer prod-
ucts, food, drinking water or indoor air.
European indicators in the field of environmental
health are limited to a few indicators in the WHO Euro-
pean Region Environment and health information sys-
tem (ENHIS1) list and in the European Core Health
Indicators (ECHI2) list [1].
ENHIS comprises levels of lead in children’s blood,
persistent organic pollutants (POPs) in human milk, ex-
posure to air pollution (particulate matter, PM) in out-
door air, exposure of children to chemical hazards in
food, and exposure of children to second-hand tobacco
smoke (SHS).
Currently there are only two European indicators
(assessing the exposure to PM 2.5, PM 10 and tobacco
smoke) assessing impacts of environmental chemicals on
health based on HBM.
From the 88 established ECHI indicators only a few
ECHIs relate to environmental health such as smoking,
consumption of fruit and vegetables, work-related health
risks (such as COPD, injuries at workplace, percentage
of employees who think their health is negatively af-
fected by their work) and PM exposure. There is no in-
dicator assessing impacts of environmental or
occupational chemicals on health in ECHI yet.
The European Environmental Agency (EEA) gather in-
formation on pollutants in air, soil, water (Environmen-
tal Core Indicators) and the European Food Safety
Agency (EFSA) collects information on intake and con-
tamination of food.
Human Biomonitoring (HBM) is a well-established
worldwide-applied methodology to assess whether and
to what extent substances have entered the body. By
measuring the concentrations of natural and synthetic
compounds in body fluids (e.g. blood, urine, and breast
milk) or tissues (e.g. hair, nails, fat, and bone), HBM can
provide information on occupational or environmental
exposures and, help identifying potential health risks.
HBM assesses the exposure in an integrated way con-
sidering all exposure pathways (inhalative, dermal, and/
or oral) and sources, and the individual susceptibility
and/or physiological status.
HBM studies are useful tools to elucidate associations
between exposure burden and health endpoints. How-
ever, it is important to note that biomonitoring must be
integrated with environmental monitoring, toxicological
data and especially with the epidemiological consider-
ations as highlighted by the European commission in the
European Environment and Health Action Plan for
2004–2010 [2].
A major European initiatives to foster use of HBM in
HI and policy making were the ‘Consortium to Perform
Human Biomonitoring on a European Scale‘(COPHES/
DEMOCOPHES)3 that established a European wide
protocol and results for plasticizers (phthalates, bisphe-
nol A) and cotinine and cadmium in urine, and mercury
in hair [3, 4]. The project was funded under the 7th
Framework Programme for Research and Technological
development, as well as the FP7 funded frameworks
‘Developing a Child Cohort Research Strategy for
Europe’ (CHICOS) and ‘Environmental Health Risks
in European Birth Cohorts’ (ENRIECO).4 CHICOS
identified all European birth cohorts [5] and
ENRIECO specifically summarized info of those
cohorts that have collected data on environmental ex-
posures [6]. The ENRIECO inventory has facilitated
the development of many collaborative studies pool-
ing data across birth cohorts with the objective to
examine the link between environmental exposures
and health outcomes [7–9].
This publication serves, within the framework of the
EU funded BRIDGE-Health project, as a comprehensive
evaluation on i) the data available on environmental
health surveillance in Europe, mainly coming from
cross-sectional and birth cohort studies and ii) the
similarities and differences between health examination
studies (HES), health register information, and human
biomonitoring (HBM). This overview was prepared with
the aim to have a better integration of environmental
health surveillance into HI and public health policies in
the EU. This aim is also pursued by the European Union
in the context of the Health in all Policies (HiAP)
strategy which stresses, among others, that health is de-
termined by the conditions in which people live, work,
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and play. This approach is also acknowledged in the
coming years, when European HBM is continued in an
H2020 funded joint programme “HBM4EU”.5 In this
context, this publication will be of fundamental import-
ance, as the HBM4EU project also aims at improving
the integration of HBM and health studies data.
Methods
We established an up-to-date inventory of chemicals
and other environmental risk factors assessed by means
of cross-sectional HBM studies, and birth cohorts. The
inventory contains information about study objectives
and collected data (analysed chemicals, matrix, sociode-
mographic characteristics of participants, etc.). The
sociodemographic characteristics of participants, and the
scientific focus of each study were summarized. The
database is easily accessible, and allows to see or rather
to compare what are the limitations and scopes of each
study. The respective information was obtained via the
project’s homepages, reports and interviews.
Information from HBM was linked with register infor-
mation (environmental databases, perinatal health regis-
ters, chronic disease registries) and health indicators,
and similarities and differences in data collection and
data management between human biomonitoring studies
and health examination surveys (HES) were evaluated.
Based on the extracted data we generated an overview of
indicators of environmental exposure and health, and
correlated them with data on human biomarkers that
are available for environmental health research. On this
basis, we derived recommendations for future work to-
wards integration of HBM in Health information (HI).
Results
State of the art of environmental health surveillance in
Europe
In Europe, there are a number of countries that run
cross-sectional HBM programmes or birth cohorts to
monitor potential impacts of environmental chemicals
on population health. The present inventory, builds on
work performed by COPHES,6 EFSA [10], and WHO
[11] as well as the work performed in the framework
of ENRIECO [6] and CHICOS [5]. It includes most
recent information collected in the course of BRIDGE
Health.
National HBM programmes and birth cohorts cover
thousands of samples from the healthy general adult
population including breast-feeding mothers and
new-born, as well as elderly women (50–65 years) and
children aged 3–17 years. Questionnaire information
covers residential environment, nutrition, smoking
behaviour, socio-economic status, exposure-relevant
life-style behaviour, and occupation. Sampled matrices
are mainly urine and blood and substance groups
covered comprise heavy metals, a broad range of organic
pollutants (e.g. PCBs (polychlorinated diphenyls), PAHs
(polycyclic aromatic hydrocarbons), PBDEs (polybromi-
nated diphenyl ethers), PCDDs (polychlorinated
dibenzo-p-dioxins), PCDFs (polychlorinated dibenzofu-
rans), organochlorines, PFCs (perfluorocarbons), phtha-
lates, herbicides, fungicides), VOCs (volatile organic
compounds), markers for tobacco smoke and allergens.
European cross-sectional HBM studies
Within Europe, several countries established cross-sectional
HBM programmes to assess environmental pollution levels
of their inhabitants as a baseline or in regular intervals. In
addition, some MS or regions in the European Union (i.e.
Flanders in Belgium, Czech Republic, and Slovenia) have
established legislation for mandatory HBM programmes
since the early years of 2000. The legal framework was
set out due to chemical incidents and industrial pol-
lution legacy. The main programmes existing in the
European Union are highlighted and presented in the
following. A more exhaustive table is available in the
Additional file 1.
The German Environmental Survey (GerES) is a na-
tionwide population representative study on human ex-
posure to environmental chemicals and its sources. The
first GerES started in 1985 and up to now, five GerES
have been conducted. In conclusion, these five studies
assessed a wide range of chemical exposure burden on
adults, children and adolescents in Germany and speci-
fied reference values, that are valuable when it comes to
policy making [12–15].
The Czech Environmental Health Monitoring System
(CZ-HBM) measured various metals, PCBs, cotinine,
and organochlorines in adults, breastfeeding primiparas,
and children (age < 12) in 1994–2003, 2005–2009, 2009–
2016 with 13,937 in each round [16].
The Flemish Environment and Health Study (FLEHS)
has been running three cycles (2002 (4400 participants),
2007 (650 participants), and 2012 (120 mother child
pairs) by now, and is currently performing its fourth
cycle (started in 2017) [17, 18]. The French Nutrition
and Health Survey (ENNS) started in 2006–2007 with a
representative sample of around 4800 children and
adults (age 3–74). A second round including children
(age 6–17) and adults (age 18–74) took place in 2014–
2015. ENNS analysed 42 chemicals in blood, urine and
hair [19]. Furthermore, the ELFE7 [20] studies deter-
mined a broad range of environmental pollutants in
children and adults.
Spain performed a representative overview of chemical
exposure in the Spanish workforce. BIOAMBIENT.ES
measured six different classes of environmental chemi-
cals in 1892 participants aged 16 or older [21]. A new
HBM survey focused on adolescents (age 14–16) has
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been initiated in 2017. This study named BEA (Biomoni-
torización En Adolescentes), studies the levels of metals
and organic pollutants in samples of blood, urine and
hair collected in 10 Spanish cities having more than
150,000 inhabitants.8 Slovenia performed a pilot survey
from 2007 to 2009 with 320 breastfeeding mothers and
their partners. In 2011 Slovenia started a follow-up
HBM study with 960 participants [22].
Italy run a population study (PROBE) with adults aged
18–65 years to determine the exposure to 20 metals and
a number of POPs on the healthy general population in
2008–2010 and 2011–2012 [23, 24].
In the Nordic countries Sweden has an environmental
monitoring program including HBM and Norway is ini-
tiating a survey [25].
Besides these population representative programmes
there are numerous smaller regional or research studies
in other European countries, which are covering similar
age groups and chemicals, as well as a European-wide
HBM pilot performed among 1844 children and their
mothers in 17 European countries (COPHES/DEMO-
COPHES), that measured phthalate compounds,
cadmium in urine, and mercury in hair [3] Table 1.
European cohort studies
Over the last 25 years, a large number of pregnancy and
birth cohorts have been established in Europe; some of
them collected information on environmental exposures.
CHICOS9 covered a total of 77 European birth cohorts
including more than 500,000 mother-child pairs [5].
ENRIECO10 included 37 of these 77 birth cohorts that
collected information on environmental exposures in-
cluding more than 350,000 study subjects [6].
Table 1 Overview on European cross-sectional HBM studies
Scientific Focus Size Age groups Matrix Chemicals Frequency
Belgium
FLEHS
Wide range of exposure
burden in Flanders,
reference values
650 new-borns and their mothers 14–
15 y/o adults 20–40 y/o adults
Cord
blood,
blood,
urine hair
metals, dioxins, PCBs, PAHs,
dichlorodiphenyltrichloroethane,
phthalates, musks, parabens and
organophosphate pesticides,
flame retardants
4× since
2002
Czech
Republic
EHMS
Core set of chemicals
measured in the Czech
population
1290 18–58 y/o adults 8–10 y/o
children breastfeeding primiparas
g
Blood
urine,
breastmilk,
teeth
metals, PCBs, cotinine,
organochlorines
Annually
since
1994
France ENNS Wide range of exposure
burden on children and
adults in France
4790 3–17 y/o children 18–74 y/o
adults
Blood,
urine hair
metals, PCBs, organochlorines,
pyrethroids, organophosphates
Once,
2006–
2007
Germany
GerES
Wide range of exposure
burden on adults, children
and adolescents in
Germany, reference values
1790–
4822
adults: GerES I-III: 18–79 y children
and adolescents: GerES III-V: 6–17
y (GerES III) 3–14 y (GerES IV) 3–17
y (GerES V) (in preparation: adults:
GerES VI: 18–79 y)
Blood
urine
metals, organochlorines,
cotinine, organophosphates,
chlorophenols, polycyclic
aromatic hydrocarbons,
pyrethroids, phthalates,
bisphenol A, phenanthrenes,
plasticiser substitutes,
pyrrolidones
5× since
1985
Italy PROBE POPs´ and metals’ internal
dose in adults to highlight
the environmental impact
on the health of Italian
population
1423 18–65 y/o adults Blood 20 metals, POPs 2× (both
2008)
Slovenia HBM
program
Pilot study for establishing
reference values for
selected chemicals in
Slovenia
320 Breast feeding first time mothers
(20–35 y/o) and their male
partners
Blood
breast milk
metals, PCBs, PBDEs, PCDDs,
PCDFs
2× (2007,
2011)
Spain-
BIOAMBI-
ENT.ES
Estimation of levels of
heavy metals and other
substances on the Spanish
active workforce
1892 Participants (≥16 y/o) Blood,
urine hair
metals, PCBs, cotinine,
organochlorines, PAHs, PBDEs,
perfluorinated alkyl substances,
phthalates, DINCH
Once,
2009–
2010
Spain BEA Study of the adolescents
to environmental
pollutants and
determinant factors
500 Adolescents (14–16 y/o) Blood,
urine, hair
Metals, bisphenols, triclosan,
phthalates and others organic
pollutants
Once,
2017
DEMOCOPHES To test the feasibility of
harmonized HBM in
Europe
1844 (~
240 per
country)
Children 6–11 y/o and their
mothers (≤ 45 y/o)
Hair urine phthalates, cadmium, mercury Once,
2010–
2012
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The oldest cohort in the ENRIECO inventory started
in 1985 whereas the youngest cohort covered by the in-
ventory started in 2011 reflecting relatively contempor-
ary environmental exposures across Europe. In all
cohorts, biological samples were collected from the
mother and/or the child and, more rarely, from the
father. Sampling covered prenatal and postnatal periods
and many types of tissue, including blood, urine, hair,
nails, breast milk, placentas, and saliva. Outdoor air pol-
lution, allergen exposures, passive smoking, and mater-
nal occupation were assessed by many birth cohorts.
Exposure areas that were less well covered in the cohorts
included noise, ionizing and non-ionizing radiations, and
chemical exposures such as brominated and fluorinated
compounds, phthalates, and phenols. Twenty-seven co-
horts measured or were measuring contaminants or
their metabolites as markers of internal dose, mostly in
the categories of metals, POPs, and tobacco smoke. A
detailed description of each of these 37 birth cohorts
and the environmental and health data collected is pro-
vided in Vrijheid et al. and Gehring et al. [6, 26].
Figure 1 presents a timeline with the beginning of
large HBM studies within Europe. The timeline shows,
that investigations of impacts of environmental chemi-
cals (and other environmental stressors) on health
started in the mid-1980s. Based and developed form
worldwide and the previous European Union projects
the European Joint Programme HBM4EU for the
harmonization and further development of HBM started
in 2017 in order to establish HBM as a prominent in-
strument to improve the policies on chemicals.
Is it possible to link register information of environmental
exposures and health indicators?
To interpret data from HBM surveys, and identify deter-
minants of exposure and potential health effects at local,
regional or national level, it is helpful if data can be
matched with information from environmental and
health registries. The environmental registries include
European data sources such as INSPIRE and IPChem
for environmental contamination, national databases in
the case of drinking water, and the database of the Euro-
pean food safety agency (EFSA) for food items. Data re-
lated to health impacts (disease registries) are found
either in national health registers [27], or at project level.
Only registers for cancer and congenital anomalies are
managed at European level by the Joint Research Centre
JRC (ENCR-JRC, EUROCAT11) to date [3]. HBM-based
indicators or data are available mainly in study databases
but will be more and more integrated in IPChem within
the currently running HBM4EU initiative. Table 2 gives
a comprehensive overview on the most important envir-
onmental and health indicator data and/or relevant in-
formation within European programs and the
corresponding human biomarkers nowadays available in
Europe. By this it gets determinable, which indicators/
data can be used in order to study either the human ex-
posure route (human biomarkers, in columns), to study
changes of the internal body burden from chemicals and
which health indicators/data and environmental indica-
tors are relevant to be linked to HBM biomarkers. A
HBM-based indicator may include information about ex-
posure routes, the occurrence of the substance in the
Fig. 1 Starting dates of (only selected) European birth cohorts and HBM programmes (abbreviations), and related harmonisation efforts (logos)
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environment or consumer good, the known health
effects and finally the internal body burden of a certain
population group. For example, Cotinine, a metabolite
from nicotine, is a good and objective marker to assess
exposure burden from tobacco smoke, and exposure
from heavy metals in food to assess ‘Exposure of children
to chemical hazards in food’ could also be much better
detected with HBM than with nutrition surveys. Add-
itional indicators might be developed for other sub-
stances of very high concern.
Differences and options for synergies with health
examination surveys (HES) – Are HBM and HES protocols
compatible?
A Health Examination Survey (HES) collects health
information from questionnaires and physical examina-
tions. This covers objective measurements such as blood
pressure, weight, height and the assessment of general
blood and urine parameters. The European Health
Examination Survey EHES12 works towards European
wide harmonisation of HES.
The combination of HBM with a Health Examination
survey enables the correlation of environmental exposure
(internal body burden) and health status and contributes
to a better understanding of the links between environ-
mental exposure, lifestyles and health effects.
There are some successful examples of large-scale pro-
grams combining HBM, HES, and nutritional surveys or
Health information surveys (HIS). The National Health
and Nutrition Examination Survey of the United States
of America (NHANES) combines a standardized phys-
ical examination in a mobile examination centre, with a
home interview to assess participants’ health [28, 29]
and collecting information on the body burden for a
broad range of chemicals in random study population
subgroups.
The Canadian Health Measure Survey (CHMS) uses a
mobile examination centre to collect health parameters
combined with a clinical questionnaire, and collects bio-
logical samples that are analysed for a broad range of en-
vironmental chemicals. Since the second Cycle of the
CHMS, also indoor air and tap water are monitored [30].
The Korean National Health and Nutrition Examin-
ation Survey (KNHANES) was established to collect de-
tailed information on health and nutrition status of
Korean citizens. In 2007, the survey became a continu-
ous, annual survey program. The survey is divided into
three parts (health interview, health examination, and
nutrition survey), and urine and blood samples are
collected from participants aged 10 years and over. In
2005 the survey was combined with a human biomoni-
toring survey, Korean national survey for environmental
pollutants in the human body (KorSEP), in order to add
information on real body burdens [31, 32].
Within Europe, a number of EU member states such
as Germany and France have established specific surveil-
lance systems for health risks from environmental
stressors, or have successfully combined HES, HIS with
population based cross-sectional HBM programmes or
longitudinal cohorts within the framework of their
national environment and health action programmes
(EHAPs).
In Germany, the German Environmental Survey
(GerES) is linked to the German Health Interview and
Examination Survey for Adults (DEGS) and for Children
and Adolescents (KiGGS) performed by the Robert Koch
Institute [33] All of the mentioned surveys collect
comprehensive data on the health status of the
respective age group. The surveys involve question-
naires, physical examinations and blood and urine col-
lection for laboratory analysis in a subsample of the
DEGS or KIGGS population. GerES performs human
biomonitoring mostly of urine and blood samples, ambi-
ent monitoring of drinking water, house dust and indoor
air and collects information on possible exposure
pathways and living conditions via questionnaires [34].
The data sets of both surveys can be used in
combination.
The French Étude Nationale Nutrition Santé (ENNS)
is combining health and nutrition studies (information
on food consumption, nutritional status, and physical ac-
tivity) in the general population in France with measure-
ments of nutritional and environmental pollutants
(HBM) in blood and urine [19]. Scandinavian countries
have successfully combined HIS and birth cohorts,
using nationwide data on social, environmental, and
health registers for research purpose (i.e. Danish
National Birth Cohort and the Norwegian Mother
and Child Cohort).
There are some similarities and differences in data col-
lection and study population between HBM and EHES
Protocols. Most important differences cover sample size,
age groups covered, questionnaire topics, tested markers,
and sample analysis. Minor differences exist as regards
recruitment, questionnaire design, interview type, exam-
ination site, sampled matrices, sampling, transport, and
storage. Training, communication, ethics, and data pro-
tection rules apply similarly to both types of surveys.
Table 3 provides an overview about major study design
aspects.
Discussion
State of the art of environmental health surveillance in
Europe
Although cross-sectional HBM programmes and birth
cohorts differ in target population, sampling scheme,
recruitment, collection of biological matrices, and the
number and types of chemicals analysed, they both
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contribute important information about impacts of
chemicals and other environmental stressors on
health.
The inventory on European HBM studies and birth
cohorts shows clear that similar chemical groups and
biological matrices are examined in cross sectional and
longitudinal large or small-scale studies.
Estimates of exposure to other environmental stressors
such as noise and PM, are usually obtained using
geographical information systems (GIS) applications and
available for a vast majority of the population and there-
fore highly suitable for environmental health surveil-
lance. Recently omics technology is coming up, in
assessing exposure-related changes in biological mole-
cules (transcriptomics, epigenomics, metabolomics, pro-
teomics) exposome is hardly used in environmental
health surveillance.
Is it possible to link register information of environmental
exposures and health indicators?
From the comprehensive Table 2 it can be seen that
within Europe, different EU institutions and reporting
schemes gather a wealth of information on pollutants in
air, soil, water, and/or food, and on diseases incidence/
prevalence.
There are a considerable number of indicators avail-
able that collect information on health, such as the
WHO European Region ENHIS (Environment and
health information system) list and the European ECHI
(European Core Health Indicators).
Indicators for environmental exposure cover the fields
of nutrition, air pollution, noise, indoor environment,
temperature, and outdoor pollution (EEA core
indicators).
There are quite a number of associations between
heavy metals, biocides, flame retardants, plasticizers,
chemicals in personal care products and VOCs, with in-
door air, food safety, consumer goods, and work-related
health risks, and there are broad association between the
vast majority of chemical groups and health indicators
or health end points such as diabetes and other meta-
bolic disorders [35], with allergies, COPD, neurological
disorders, and perinatal health [36], as well as associ-
ation between certain chemical and cancer [37, 38],
which are not reflected in HI yet. This is for example
true for heavy metals, which concentrations get deter-
mined routinely, when indoor air- or water quality is
measured. However, the fact that heavy metals are also
related to various health outcomes like for example, dia-
betes or neurologic outcomes, is not acknowledged by
any available database. The other way around, when
Table 3 Important parameter in HBM and HES study design
Key parameter HBM studies HES (according to EHESa)
Study
population
General adult population:
Adults (18–79 years)
Specific population/vulnerable groups:
Children and adolescents (3–17 years)
Breastfeeding mothers
Mothers and their new born
Older women 50–65 years
General adult population:
500 of each of the eight age-sex domains
(25–34, 35–44, 45–54 and 55–64 years)
Questionnaire
topics
Residential environment and residence
Nutrition (with focus on exposure related food intake)
Smoking behaviour
Exposure-relevant behaviour (mother’s) occupation
Socio-demography and socio-economic status
Based on the EHIS.
Health status (self-perceived, chronic
morbidity, activity limitations)
Health care (hospitalisation)
Health determinants (height, weight, physical activity)
Background variables (education, labour status)
Sample
matrixb
Blood (10/11)
Urine (8/11)
Scalp hair (4/11)
Breast milk (2/11)
Cord blood (1/11)
Teeth (1/11)
Blood
Urine
Tested
markers
Heavy Metals: Cd, Pb, Hg
Manmade chemicals (PCBs, PAHs, PBDEs, PCDDs, PCDFs,
organochlorine, VOCs, PFCs, Phthalate, herbicide, fungicide)
Biological: IgE, Cotinine etc.
Biological
Glucose
Total cholesterol
HDL
Anthropometrical
Weight
Height
Blood pressure
Waist circumference
ahttp://www.ehes.info/
bSample matrix data assessed by Table 4 of Supplemental material
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looked at health outcomes in the case of diabetes, there
is also no link between this NCD and several stressors
like POPs, the mentioned heavy metals, and plastic
compounds..
Hence there is a need to integrate environmental
health research and surveillance into the EU Health in-
formation system. To improve surveillance and monitor-
ing strategies, the field of indicators are coming to the
fore. Indicators are tools to detect positive or negative
developments in different fields of actions, such as envir-
onmental protection or sustainability and can highlight
success or failure of actions that have been taken.
Consequently, indicators are used as a control instru-
ment that delivers information about the progress that
has been made in reaching special goals (e.g. to
minimize exposure burden from environmental
chemicals in the European population).
But indicators are not commonly linked to each other.
This publication points out, that there is a great poten-
tial in the linking of indicators of various fields (chemical
exposure, health outcomes) in terms of determining en-
vironmental health in a more adequate manner. This is
of importance when it comes to the transformation
process of science into policies, as only a valid presenta-
tion of chemical exposure in terms by indicators is suit-
able for the definition of legally enforceable and binding
health-based guidance value reference values.
Differences and options synergies with health
examination surveys (HES)
The direct comparison of HBM- and HES-studies show,
that there are a lot of similarities in the fieldwork part of
the study design, in sampling, data management, quality
and ethical issues, so that despite differences in the study
population, questionnaire, matrix and chemical analysis,
it should be possible to combine HES, chemical bio-
marker assessment in humans not only at national but
also at European level, if certain adaptations are made.
To our knowledge, this publication represents the first
direct comparison of HBM- and HES-parameters. As
already elaborated upon, there are great synergies be-
tween those two study types, which can have, if used in
appropriate means, a large added value in impacting
environmental health policy making.
Conclusions
Given the wealth of information that HBM may provide
on environmental determinants for health and the lack
of tools to report on it at the level of the European
Union, there is an urgent need to integrate environmen-
tal health research and surveillance into an EU Health
information system, and into EU public health and con-
sumer protection policies.
The current inconsistencies in data collections in the
existing databases and reporting schemes for HBM,
environmental, nutrition and disease registries strongly
hamper the usability of data. However, there is consider-
able perspective to align data collection. in terms of
geographical stratification, temporal changes, informa-
tion on life-style, potential exposure and socio-economic
risks.
Regarding HBM and HES surveys there are also
considerable differences but at the same time they can
be performed together, improving its cost-efficiency.
There is a need for considerable further efforts to gener-
ate appropriate indicators for monitoring exposure
burden levels to environmental chemicals. Aside from
the indicator data collected within the EU institutions, it
would be advisable to have additional EU wide indicators
in the field of: (i) environmental health: e.g. HBM bio-
markers, occupational groups, noise level (in cities),
environments, (heavy) traffic density, as well as (ii)
health: allergy, infections, growth, behaviour data,
spontaneous abortions.
Based on these conclusions it can be recommended to:
Include environmental health information in a Euro-
pean Health information system (HIS) in order to meet
the requirements of the Agenda 2030, and its SDG3, and
to integrate HBM-based indicators for environmental
health on existing lists, like ECHI.
A first step towards this goal should be a better align-
ment of health, environmental health, environmental,
and administrative data and data collections and bases,
as well as of HES survey design with HBM surveys and
cohorts. For now, a first step would be to evaluate the
data sets available on European level, combining all the
current indicators/biomarker, as suggested in Table 2.
Combining the information offers the possibility to cre-
ate a complete European Environmental Health surveil-
lance and warning system. Indeed, trends in these
indicators and exceedances above health-based guidance
values allow estimating or identifying (upcoming) poten-
tial health risks.
The alignment of HBM’s and HES´ study designs in-
cludes the adaption of the target populations, the ques-
tionnaires, and the chemical analysis. HES should be
expanded to cover also children, adolescents, and
new-borns with their mothers in the surveys. The ques-
tionnaire should comprise questions about potential ex-
posure sources. The sampling could be expanded to
cover hair and milk, and the chemical analysis should
comprise at least some priority chemicals. Whereby the
acquired personal data needs to be treated based on the
new General Data Protection Regulation (GDPR) to be
implemented as of May 25th, 2018 will require further
harmonization on a European level. Whilst further work
on HBM specific issues such as PBPK models, derivation
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of health based guidance values, development of
HBM-based indicators, combination of HBM- and
Health-Studies etc. will be performed in the European
Human Biomonitoring Initiative HBM4EU,13 Health in-
formation specific topics such as integration of HBM
relevant information in health and patient data registries
allowing to trace back to occupation, life style, exposure
or socio-economic status, or indicator development
should be covered by any joint action or research infra-
structure on Health Information, as a follow-up to
BRIDGE Health in close cooperation with HBM4EU.
Endnotes
1WHO: http://data.euro.who.int/eceh-enhis/
Default2.aspx?indicator_id=19
2European Commission: https://ec.europa.eu/health/
indicators/echi/list_en
3(http://www.eu-hbm.info/cophes)
4http://www.enrieco.org/
5www.HBM4EU.eu
6http://www.eu-hbm.info/cophes/a-special-issue-201-
charmonized-human-biomonitoring-on-a-european-sca
le-experiences-in-seventeen-countries201d-has-been-is
sued-in-august-2015-in-environmental-research
7https://www.elfe-france.fr/en/
8(http://bea.blogs.isciii.es/).
9www.birthcohorts.net
10www.enrieco.dk
11http://www.eurocat-network.eu/
12http://www.ehes.info/
13https://www.hbm4eu.eu/
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